You are here

China's stifling laws depriving its people of common vaccines

They also pose a challenge to global pharmaceutical firms in a huge potential market

BT_20160415_VACCINE_2225918.jpg
More than 30 vaccine products identified by top multinationals as major revenue generators in other parts of the world aren’t sold on the mainland, according to McKinsey & Co.

joflu07150416.jpg
Stifling regulations are preventing China's 1.4 billion people from accessing several common vaccines available in much of the rest of the world, raising public health risks and posing a challenge to global pharmaceutical companies in a huge potential market.

Beijing

STIFLING regulations are preventing China's 1.4 billion people from accessing several common vaccines available in much of the rest of the world, raising public health risks and posing a challenge to global pharmaceutical companies in a huge potential market.

Sam Ding, a

sentifi.com

Market voices on:

Powered by GET.comGetCom